S100A8 and S100A9 are NF-kB target genes in human HCC cells during inflammation-associated liver carcinogenesis and increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death [56]. Here, NFKB1 is linked to hepatocellular carcinoma.